Matches in UGent Biblio for { <https://biblio.ugent.be/publication/3088172#aggregation> ?p ?o. }
Showing items 1 to 35 of
35
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B377815.
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation date "2012".
- aggregation format "application/pdf".
- aggregation hasFormat 3088172.bibtex.
- aggregation hasFormat 3088172.csv.
- aggregation hasFormat 3088172.dc.
- aggregation hasFormat 3088172.didl.
- aggregation hasFormat 3088172.doc.
- aggregation hasFormat 3088172.json.
- aggregation hasFormat 3088172.mets.
- aggregation hasFormat 3088172.mods.
- aggregation hasFormat 3088172.rdf.
- aggregation hasFormat 3088172.ris.
- aggregation hasFormat 3088172.txt.
- aggregation hasFormat 3088172.xls.
- aggregation hasFormat 3088172.yaml.
- aggregation isPartOf urn:issn:0891-6640.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Veterinary Sciences".
- aggregation title "Recombinant human thyrotropin in veterinary medicine: current use and future perspectives".
- aggregation abstract "Recombinant human thyrotropin (rhTSH) was developed after bovine thyrotropin (bTSH) was no longer commercially available. It was approved by the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) as an aid to diagnostic follow-up of differentiated thyroid carcinoma in humans and for thyroid remnant ablation with radioiodine. In addition, rhTSH is used in human medicine to evaluate thyroid reserve capacity and to enhance radioiodine uptake in patients with metastatic thyroid cancer and multinodular goiter. Likewise, rhTSH has been used in veterinary medicine over the last decade. The most important veterinary use of rhTSH is thyroidal functional reserve testing for the diagnosis of canine hypothyroidism. Recent pilot studies performed at Ghent University in Belgium have investigated the use of rhTSH to optimize radioiodine treatment of canine thyroid carcinoma and feline hyperthyroidism. Radioiodine treatment optimization may allow a decreased therapeutic dosage of radioiodine and thus may improve radioprotection. This review outlines the current uses of rhTSH in human and veterinary medicine, emphasizing research performed in dogs and cats, as well as potential future applications.".
- aggregation authorList BK682274.
- aggregation endPage "862".
- aggregation issue "4".
- aggregation startPage "853".
- aggregation volume "26".
- aggregation aggregates 3095700.
- aggregation isDescribedBy 3088172.
- aggregation similarTo j.1939-1676.2012.00950.x.
- aggregation similarTo LU-3088172.